Download PDF
Clin Colon Rectal Surg 2010; 23(3): 176-181
DOI: 10.1055/s-0030-1262985
© Thieme Medical Publishers

Enterocutaneous Fistula Associated with Malignancy and Prior Radiation Therapy

Luiz Felipe de Campos-Lobato1 , Jon D. Vogel1
  • 1Department of Colorectal Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio
Further Information

Publication History

Publication Date:
24 August 2010 (online)

    Permissions and Reprints

ABSTRACT

Enterocutaneous fistula (ECF) associated with cancer or radiation injury increases the complexity of normal management. Factors such as timing of additional adjuvant therapy or palliative care, technical considerations for operating on irradiated bowel, poor wound healing, increased risk of additional ECF, and decreased likelihood of spontaneous ECF closure all need to be considered in this scenario. Here the authors focus specifically on the management of ECF associated with cancer and/or radiation-induced injury to the bowel.

KEYWORDS

Enterocutaneous fistula - cancer - radiation injury - management

REFERENCES

  • 1 Edmunds Jr L H, Williams G M, Welch C E. External fistulas arising from the gastro-intestinal tract.  Ann Surg. 1960;  152 445-471
    CrossrefPubMedGoogle Scholar
  • 2 Joyce M R, Dietz D W. Management of complex gastrointestinal fistula.  Curr Probl Surg. 2009;  46(5) 384-430
    CrossrefPubMedGoogle Scholar
  • 3 Chamberlain R S, Kaufman H L, Danforth D N. Enterocutaneous fistula in cancer patients: etiology, management, outcome, and impact on further treatment.  Am Surg. 1998;  64(12) 1204-1211
    PubMedGoogle Scholar
  • 4 Paris F, Fuks Z, Kang A et al.. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice.  Science. 2001;  293(5528) 293-297
    CrossrefPubMedGoogle Scholar
  • 5 Zimmerer T, Böcker U, Wenz F, Singer M V. Medical prevention and treatment of acute and chronic radiation induced enteritis—is there any proven therapy? A short review.  Z Gastroenterol. 2008;  46(5) 441-448
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Sauer R, Becker H, Hohenberger W German Rectal Cancer Study Group et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer.  N Engl J Med. 2004;  351(17) 1731-1740
    CrossrefPubMedGoogle Scholar
  • 7 Morganti A G, Massaccesi M, La Torre G et al.. A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer.  Ann Surg Oncol. 2010;  17(1) 194-205
    CrossrefPubMedGoogle Scholar
  • 8 Rogers L, Siu S S, Luesley D, Bryant A, Dickinson H O. Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer.  Cochrane Database Syst Rev. 2009;  (4) CD007583
    PubMedGoogle Scholar
  • 9 Stratton K L, Chang S S. Locally advanced prostate cancer: the role of surgical management.  BJU Int. 2009;  104(4) 449-454
    CrossrefPubMedGoogle Scholar
  • 10 Lynch A C, Delaney C P, Senagore A J, Connor J T, Remzi F H, Fazio V W. Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery.  Ann Surg. 2004;  240(5) 825-831
    CrossrefPubMedGoogle Scholar
  • 11 Gordon P H. Principles and practice of surgery for the colon, rectum, and anus. In: Gordon PH, Nivatvongs S Principles and Practice of Surgery for the Colon, Rectum, and Anus. New York; Informa Health Care 2007: 104-134
    PubMedGoogle Scholar
  • 12 Corman M L. Colon and Rectal Surgery. Philadelphia; Lippincott Williams & Wilkins 2005
    PubMedGoogle Scholar
  • 13 Kozelsky T F, Meyers G E, Sloan J A North Central Cancer Treatment Group et al. Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy.  J Clin Oncol. 2003;  21(9) 1669-1674
    CrossrefPubMedGoogle Scholar
  • 14 Meissner K. Late radiogenic small bowel damage: guidelines for the general surgeon.  Dig Surg. 1999;  16(3) 169-174
    CrossrefPubMedGoogle Scholar
  • 15 Giantonio B J, Catalano P J, Meropol N J Eastern Cooperative Oncology Group Study E3200 et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.  J Clin Oncol. 2007;  25(12) 1539-1544
    CrossrefPubMedGoogle Scholar
  • 16 Sandler A, Gray R, Perry M C et al.. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.  N Engl J Med. 2006;  355(24) 2542-2550
    CrossrefPubMedGoogle Scholar
  • 17 Wedam S B, Low J A, Yang S X et al.. Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer.  J Clin Oncol. 2006;  24(5) 769-777
    CrossrefPubMedGoogle Scholar
  • 18 Kindler H L, Friberg G, Singh D A et al.. Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.  J Clin Oncol. 2005;  23(31) 8033-8040
    CrossrefPubMedGoogle Scholar
  • 19 Yang J C, Haworth L, Sherry R M et al.. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.  N Engl J Med. 2003;  349(5) 427-434
    CrossrefPubMedGoogle Scholar
  • 20 Scappaticci F A, Fehrenbacher L, Cartwright T et al.. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.  J Surg Oncol. 2005;  91(3) 173-180
    CrossrefPubMedGoogle Scholar
  • 21 Heinzerling J H, Huerta S. Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management.  Curr Surg. 2006;  63(5) 334-337
    CrossrefPubMedGoogle Scholar
  • 22 Sugarbaker P H. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.  Eur J Surg Oncol. 2001;  27(3) 239-243
    CrossrefPubMedGoogle Scholar
  • 23 Esquivel J, Sticca R, Sugarbaker P Society of Surgical Oncology Annual Meeting et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement.  Ann Surg Oncol. 2007;  14(1) 128-133
    PubMedGoogle Scholar
  • 24 Jaehne J. Cytoreductive procedures-strategies to reduce postoperative morbidity and management of surgical complications with special emphasis on anastomotic leaks.  J Surg Oncol. 2009;  100(4) 302-305
    CrossrefPubMedGoogle Scholar
  • 25 Yan T D, Morris D L. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care?.  Ann Surg. 2008;  248(5) 829-835
    PubMedGoogle Scholar
  • 26 Roviello F, Marrelli D, Neri A et al.. Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity.  World J Surg. 2006;  30(11) 2033-2040, discussion 2041–2042
    CrossrefPubMedGoogle Scholar
  • 27 Schmidt S, Chevallier P, Bessoud B et al.. Diagnostic performance of MRI for detection of intestinal fistulas in patients with complicated inflammatory bowel conditions.  Eur Radiol. 2007;  17(11) 2957-2963
    CrossrefPubMedGoogle Scholar
  • 28 Salerno G, Daniels I R, Moran B J, Wotherspoon A, Brown G. Clarifying margins in the multidisciplinary management of rectal cancer: the MERCURY experience.  Clin Radiol. 2006;  61(11) 916-923
    CrossrefPubMedGoogle Scholar
  • 29 Brown G, Daniels I R. Preoperative staging of rectal cancer: the MERCURY research project.  Recent Results Cancer Res. 2005;  165 58-74
    PubMedGoogle Scholar
  • 30 Outwater E, Schiebler M L. Pelvic fistulas: findings on MR images.  AJR Am J Roentgenol. 1993;  160(2) 327-330
    PubMedGoogle Scholar
  • 31 Bartram C, Buchanan G. Imaging anal fistula.  Radiol Clin North Am. 2003;  41(2) 443-457
    CrossrefPubMedGoogle Scholar
  • 32 Semelka R C, Hricak H, Kim B et al.. Pelvic fistulas: appearances on MR images.  Abdom Imaging. 1997;  22(1) 91-95
    CrossrefPubMedGoogle Scholar
  • 33 Pilleul F, Godefroy C, Yzebe-Beziat D, Dugougeat-Pilleul F, Lachaux A, Valette P J. Magnetic resonance imaging in Crohn's disease.  Gastroenterol Clin Biol. 2005;  29(8-9) 803-808
    CrossrefPubMedGoogle Scholar
  • 34 Albert J G, Martiny F, Krummenerl A et al.. Diagnosis of small bowel Crohn's disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis.  Gut. 2005;  54(12) 1721-1727
    CrossrefPubMedGoogle Scholar
  • 35 Gourtsoyiannis N C, Grammatikakis J, Papamastorakis G et al.. Imaging of small intestinal Crohn's disease: comparison between MR enteroclysis and conventional enteroclysis.  Eur Radiol. 2006;  16(9) 1915-1925
    CrossrefPubMedGoogle Scholar
  • 36 Masselli G, Casciani E, Polettini E, Lanciotti S, Bertini L, Gualdi G. Assessment of Crohn's disease in the small bowel: Prospective comparison of magnetic resonance enteroclysis with conventional enteroclysis.  Eur Radiol. 2006;  16(12) 2817-2827
    CrossrefPubMedGoogle Scholar
  • 37 Kwon S H, Oh J H, Kim H J, Park S J, Park H C. Interventional management of gastrointestinal fistulas.  Korean J Radiol. 2008;  9(6) 541-549
    CrossrefPubMedGoogle Scholar
  • 38 Chapman R, Foran R, Dunphy J E. Management of intestinal fistulas.  Am J Surg. 1964;  108 157-164
    CrossrefPubMedGoogle Scholar
  • 39 Schecter W P, Hirshberg A, Chang D S et al.. Enteric fistulas: principles of management.  J Am Coll Surg. 2009;  209(4) 484-491
    CrossrefPubMedGoogle Scholar
  • 40 Hill G L. Operative strategy in the treatment of enterocutaneous fistulas.  World J Surg. 1983;  7(4) 495-501
    CrossrefPubMedGoogle Scholar
  • 41 Cameron J. Current Surgical Therapy. St. Louis, MO; Mosby 2001
    PubMedGoogle Scholar
  • 42 Galie K L, Whitlow C B. Postoperative enterocutaneous fistula: when to reoperate and how to succeed.  Clin Colon Rectal Surg. 2006;  19(4) 237-246
    Article in Thieme ConnectPubMedGoogle Scholar
  • 43 Quah H M, Chou J F, Gonen M et al.. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.  Dis Colon Rectum. 2008;  51(5) 503-507
    CrossrefPubMedGoogle Scholar
  • 44 Lavery I C, de Campos-Lobato L F. How to evaluate and identify stage II colon cancer patients requiring referral to a medical oncologist: a surgeons perspective.  Oncology (Williston Park). 2010;  24(1, Suppl 1) 14-16
    PubMedGoogle Scholar
  • 45 Willett C G, Czito B G. Chemoradiotherapy in gastrointestinal malignancies.  Clin Oncol (R Coll Radiol). 2009;  21(7) 543-556
    CrossrefPubMedGoogle Scholar
  • 46 Colombo N, Parma G, Zanagnolo V, Insinga A. Management of ovarian stromal cell tumors.  J Clin Oncol. 2007;  25(20) 2944-2951
    CrossrefPubMedGoogle Scholar
  • 47 Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration . Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials.  J Clin Oncol. 2008;  26(35) 5802-5812
    CrossrefPubMedGoogle Scholar
  • 48 Marks G, Mohiudden M. The surgical management of the radiation-injured intestine.  Surg Clin North Am. 1983;  63(1) 81-96
    PubMedGoogle Scholar
  • 49 Galland R B, Spencer J. Radiation-induced gastrointestinal fistulae.  Ann R Coll Surg Engl. 1986;  68(1) 5-7
    PubMedGoogle Scholar
  • 50 Galland R B, Spencer J. Surgical management of radiation enteritis.  Surgery. 1986;  99(2) 133-139
    PubMedGoogle Scholar
  • 51 Cooke S A, de Moor N G. The surgical treatment of the radiation-damaged rectum.  Br J Surg. 1981;  68(7) 488-492
    CrossrefPubMedGoogle Scholar
  • 52 Galland R B, Spencer J. Surgical aspects of radiation injury to the intestine.  Br J Surg. 1979;  66(2) 135-138
    CrossrefPubMedGoogle Scholar
  • 53 Dworak J, Dietz D W. Radiation enteritis and proctitis. In: Fazio VW, Church JM, Delaney C Current Therapy in Colon and Rectal Surgery. Philadelphia, PA; Elsevier Mosby 2004: 491-498
    PubMedGoogle Scholar
  • 54 Landim F M, Tavares J M, Costa M L, Landim R M, Feitosa R G. Complex abdominal wall reconstruction after radiation therapy: a full-thickness defect was repaired with a rectus femoris myofasciocutaneous flap.  Am J Obstet Gynecol. 2009;  200(1) 116.e1-116.e3
    PubMedGoogle Scholar

Jon D VogelM.D. 

9500 Euclid Ave.

A30, Cleveland, OH 44195. Reprints will not be made available.

Email: vogelj@ccf.org

      >